Imagine doctors being able to scan your DNA from a biopsy and pinpoint the medicine that will work best for you. It’s a high-tech approach that scientists at The Ohio State Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute are already using, particularly when it comes to lung cancer, the deadliest form of the cancer in the U.S. “We get the DNA, put it onto a chip, and we test 50 different genes at once,” said Gregory Otterson, MD an oncologist who specializes in molecular biology and cancer genetics. “That allows us very quickly to determine which drugs will be effective for your particular cancer, and which won’t,” he said. That’s especially important in lung cancer because the vast majority of patients are diagnosed in the later stages, meaning it’s important to start effective therapies quickly. This coverage resulted from pitching efforts and a multimedia release distributed by OSU Wexner Medical Center Public Affairs and Media Relations, available online at: http://cancer.osu.edu/mediaroom/releases/Pages/lungcancergenomicsequencing.aspx.